| Outcome Measures: |
Primary: Δ 2-h AUC C-peptide response, 1 month, 3 months, 6 months, 9 months | Secondary: Incremental and/or peak C-peptide response, Time to peak C-peptide, insulin requirement per kg body weight per day,frequency of insulin free state with maintenance of HbA1c <7.5%, HbA1c, Means of fasting glucose values, circulating IL-6 and CRP, 1 month, 3 months, 6 months, 9 months
|
| Locations: |
Aalborg Hospital, Aalborg, 9100, Denmark|Aarhus Universitetshospital, Aarhus, 8000 C, Denmark|Bispebjerg Universitetshospital, Copenhagen, 2400 NV, Denmark|Steno Diabetes Center, Gentofte, 2820, Denmark|Nordsjællands Hospital, Hillerød, Hillerød, 3400, Denmark|Ulm University, Dept. of Internal Medicine, Ulm, Donau, 89081, Germany|Leibniz Center for Diabetes research, Heinrich-Heine University, Duesseldorf, 40225, Germany|University of Frankfurt am Main, Frankfurt am Main, 60590, Germany|Institut für Diabetesforschung, Munich University of Technology, Munich, 80804, Germany|University Campus Bio-Medico, Rome, 00128, Italy|Leiden University Medical Center, Leiden, 2300 RC, Netherlands|Medical University of Bialystok, Bialystok, 15-269, Poland|Hospital de Cruces, Diabetes Research Group, Barakaldo, Bizkaia, 48903, Spain|Hospital Unversitario Insular de Gran Canaria, Las Palmas, Gran Canaria, 35016, Spain|Hospital Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Arnua de Vilanova, Lleida, 25198, Spain|University Hospital Zürich, Zürich, CH-8091, Switzerland
|
